|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Pulmonary Hypertension | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hypertension | |||||
| Hypertension, Pulmonary | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Lung Diseases | |||||
| Respiratory Tract Diseases | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Ambrisentan | |||||
| 5 | Sponsors listed in this trial | ||||
| Gilead Sciences | |||||